Broaden your audience, analyst tells biotechs
Tuesday, 16 September, 2003
Biotechnology companies need to widen the audiences they pitch their messages to, industry analyst David Blake, of BioShares, told attendees at a BioMelbourne Network breakfast meeting today.
"You have to go beyond the audiences you think you want to talk to," said Blake.
He noted that while it was important to communicate with stakeholders including shareholders, regulatory bodies, and potential investors, companies needed to also develop messages for consumers, non-investors, and society's decision makers, including policy makers. And companies should not ignore other economic sectors either.
It was also important to develop positive relationships with the media, and not just with the business-focused media, Blake said. Negative images had the potential to affect the whole industry, not just one company, he said.
"If you can't describe the benefits to all of these audiences, then you should get out of the game," Blake said.
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

